Eczema epidemiology and demographics

	Eczema Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Eczema from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Social Impact
Future or Investigational Therapies
Case Studies
Case #1
Eczema On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Eczema All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Eczema
CDC on Eczema
Eczema in the news
Blogs on Eczema
Directions to Hospitals Treating Eczema
Risk calculators and risk factors for Eczema

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.

Overview

In the United States, eczema has a prevalence of 10.7% in children and 7.2% in adults. ^[1] ^[2] Eczema has more predilection in males. ^[3]

A recent study showed that persistence of disease 8 years from the onset is noted in 20% of children.^[4]
Eczema has more predilection in males. ^[3]
In the United States, eczema has a prevalence of 10.7% in children and 7.2% in adults. ^[5]^[6] Eczema has more predilection in males. ^[3]

↑ Shaw TE, Currie GP, Koudelka CW, Simpson EL (2011). "Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health". J Invest Dermatol. 131 (1): 67–73. doi:10.1038/jid.2010.251. PMC 3130508. PMID 20739951.
↑ Silverberg JI, Garg NK, Paller AS, Fishbein AB, Zee PC (2015). "Sleep disturbances in adults with eczema are associated with impaired overall health: a US population-based study". J Invest Dermatol. 135 (1): 56–66. doi:10.1038/jid.2014.325. PMID 25078665.
↑ ^3.0 ^3.1 ^3.2 Hanifin JM, Reed ML, Eczema Prevalence and Impact Working Group (2007). "A population-based survey of eczema prevalence in the United States". Dermatitis. 18 (2): 82–91. doi:10.2310/6620.2007.06034. PMID 17498413.
↑ Kim JP, Chao LX, Simpson EL, Silverberg JI (2016). "Persistence of atopic dermatitis (AD): A systematic review and meta-analysis". J Am Acad Dermatol. 75 (4): 681–687.e11. doi:10.1016/j.jaad.2016.05.028. PMC 5216177. PMID 27544489.
↑ Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID 10.1038/jid.2010.251. doi: 10.1038/jid.2010.251. Check |pmid= value (help).
↑ Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID 10.1038/jid.2014.325. doi: 10.1038/jid.2014.325. Check |pmid= value (help).